DrugPatentWatch Database Preview
Litigation Details for Alkermes Pharma Ireland Limited v. Mylan Pharmaceuticals Inc. (D. Del. 2012)
» See Plans and Pricing
Alkermes Pharma Ireland Limited v. Mylan Pharmaceuticals Inc. (D. Del. 2012)
Docket | Start Trial | Date Filed | 2012-12-06 |
Court | District Court, D. Delaware | Date Terminated | 2014-05-19 |
Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
Jury Demand | None | Referred To | |
Patents | 6,228,398; 6,730,325 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Alkermes Pharma Ireland Limited v. Mylan Pharmaceuticals Inc.
Details for Alkermes Pharma Ireland Limited v. Mylan Pharmaceuticals Inc. (D. Del. 2012)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2012-12-06 | 1 | United States Patent Nos. 6,228,398 (“the ’398 patent”) and 6,730,325 (“the ’325 patent”). This action…certification with respect to the ’398 patent constituted infringement of that patent. This is an exceptional case…certification with respect to the ’325 patent constituted infringement of that patent. This is an exceptional case… than the expiration dates of the ’398 patent and ’325 patent, including any extensions; …action is based upon the Patent Laws of the United States, 35 U.S.C. § 100 et seq. Case 1:12-cv-01673 | External link to document | |
2014-05-19 | 27 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,228,398 B1; 6,730,325 B2. (… 2012 19 May 2014 1:12-cv-01673 830 Patent None District Court, D. Delaware | External link to document | |
2012-12-06 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,228,398 B1; 6,730,325 B2;. … 2012 19 May 2014 1:12-cv-01673 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |